These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Opposing effects of fatty acids and acyl-CoA esters on conformation and cofactor recruitment of peroxisome proliferator-activated receptors. JØrgensen C; Krogsdam AM; Kratchmarova I; Willson TM; Knudsen J; Mandrup S; Kristiansen K Ann N Y Acad Sci; 2002 Jun; 967():431-9. PubMed ID: 12079871 [TBL] [Abstract][Full Text] [Related]
24. Triglycerides, fatty acids and insulin resistance--hyperinsulinemia. Kraegen EW; Cooney GJ; Ye J; Thompson AL Exp Clin Endocrinol Diabetes; 2001; 109(4):S516-26. PubMed ID: 11453039 [TBL] [Abstract][Full Text] [Related]
25. Elevated free fatty acids attenuate the insulin-induced suppression of PDK4 gene expression in human skeletal muscle: potential role of intramuscular long-chain acyl-coenzyme A. Tsintzas K; Chokkalingam K; Jewell K; Norton L; Macdonald IA; Constantin-Teodosiu D J Clin Endocrinol Metab; 2007 Oct; 92(10):3967-72. PubMed ID: 17652214 [TBL] [Abstract][Full Text] [Related]
26. [The role of fatty acids in gene regulation. An example of an important nutritional factor which may influence our genes]. Endresen MJ Tidsskr Nor Laegeforen; 1995 Jun; 115(17):2084-6. PubMed ID: 7644988 [TBL] [Abstract][Full Text] [Related]
27. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle. Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029 [TBL] [Abstract][Full Text] [Related]
28. Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation. Fredenrich A; Grimaldi PA Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):377-81. PubMed ID: 15192438 [TBL] [Abstract][Full Text] [Related]
29. Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals. Codner E; Loviscach M; Ciaraldi TP; Rehman N; Carter L; Mudaliar S; Henry RR Metabolism; 2001 Jul; 50(7):830-4. PubMed ID: 11436190 [TBL] [Abstract][Full Text] [Related]
30. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850 [TBL] [Abstract][Full Text] [Related]
31. Updating the effects of fatty acids on skeletal muscle. Silveira LR; Fiamoncini J; Hirabara SM; Procópio J; Cambiaghi TD; Pinheiro CH; Lopes LR; Curi R J Cell Physiol; 2008 Oct; 217(1):1-12. PubMed ID: 18543263 [TBL] [Abstract][Full Text] [Related]
32. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma. Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955 [TBL] [Abstract][Full Text] [Related]
33. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action. Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442 [TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance. Voss MD; Beha A; Tennagels N; Tschank G; Herling AW; Quint M; Gerl M; Metz-Weidmann C; Haun G; Korn M Diabetologia; 2005 Dec; 48(12):2622-30. PubMed ID: 16284748 [TBL] [Abstract][Full Text] [Related]
36. IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a fiber specific manner. Lane RH; Maclennan NK; Daood MJ; Hsu JL; Janke SM; Pham TD; Puri AR; Watchko JF Pediatr Res; 2003 Jun; 53(6):994-1000. PubMed ID: 12646730 [TBL] [Abstract][Full Text] [Related]
37. [Effects of fenofibrate on the expression of peroxisome proliferator-activated-gamma coactivator-1α in skeletal muscle of rats infused with intralipid]. Bai XP; Li HL; Yang WY; Xiao JZ; Wang B Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2856-9. PubMed ID: 21162799 [TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475 [TBL] [Abstract][Full Text] [Related]
39. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Nagai Y; Nishio Y; Nakamura T; Maegawa H; Kikkawa R; Kashiwagi A Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1180-90. PubMed ID: 11934685 [TBL] [Abstract][Full Text] [Related]
40. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Leone TC; Weinheimer CJ; Kelly DP Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7473-8. PubMed ID: 10377439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]